Sarepta Therapeutics (SRPT) Gets a Hold from Scotiabank
In a report released today, Louise Chen from Scotiabank maintained a Hold rating on Sarepta Therapeutics (SRPT – Research Report), with a price ...
Scotiabank Sticks to Its Buy Rating for Palvella Therapeutics (PVLA)
In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Palvella Therapeutics (PVLA – Research Report), with a price ...
Scotiabank Reaffirms Their Buy Rating on Avidity Biosciences (RNA)
In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Avidity Biosciences (RNA – Research Report), with a price ...
Dyne Therapeutics (DYN) Gets a Buy from Scotiabank
In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Dyne Therapeutics (DYN – Research Report), with a price ...
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB – Research Report), Perspective ...
Zai Lab price target raised to $51 from $44 at JPMorgan
JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models ...
Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer
Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, ...
Zai Lab (ZLAB) Initiated with a Buy at Scotiabank
Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s ...
Cogent Biosciences (COGT) Initiated with a Buy at Scotiabank
Cogent Biosciences (COGT – Research Report) received a Buy rating and a $17.00 price target from Scotiabank analyst Louise Chen today. The ...
Today14d
I tried the $19 Erewhon strawberry. Is it worth the splurge?
It’s the strawberry that made the internet go bananas. In late February, influencer Alyssa Antoci — whose family owns luxury Los Angeles grocer Erewhon — posted a TikTok about a rather pricy ...
Zai Lab initiated with an Outperform at Scotiabank
Scotiabank initiated coverage of Zai Lab (ZLAB) with an Outperform rating and $55 price target The firm says that although geopolitical risk ...
ETF Daily News14d
Cantor Fitzgerald Upgrades Zai Lab (NASDAQ:ZLAB) to “Strong-Buy”
Shares of ZLAB opened at $35.39 on Tuesday. Zai Lab has a one year low of $13.48 and a one year high of $36.60. The stock has a 50-day moving average price of $28.10 and a 200 day moving average ...